US farm with 93,000 hectares for sale: 10,000 cattle on 2 islands.
10,000 cattle, deer, bison, and a slaughterhouse in the middle of nowhere. One of the largest slaughterhouses in Alaska is located on the storm-battered Umnak Island.
The General Meeting of Bayer agrees to a capital increase
The General Meeting of Bayer has agreed to a capital increase. The money is to be used as security for the lawsuits against glyphosate in the USA. The restructuring within the company continues in the meantime.
Bayer looks positively to the future
The Bayer Group looks positively to the future, especially since shareholders agreed last week to a capital increase of up to 35%. Bayer will primarily use this for security in the ongoing wave of lawsuits related to glyphosate in the USA.
Bayer remains resilient in lawsuits
Bayer aims to significantly reduce legal risks by the end of 2026. The company will continue to vigorously defend itself and appeal against any negative judgments. It recently filed a request with the highest court in the USA to determine if US federal law excludes lawsuits due to alleged lack of warning labels on glyphosate products.
Authorized capital is in the interest of shareholders
In terms of cash and debt reduction, Bayer reduced its net financial debt to €32.6 billion last year. However, the debt is still too high, and further reduction is closely linked to measures to reduce legal risks. To gain flexibility in containing legal disputes and maintaining an appropriate credit rating, the company asked the General Meeting to approve a potential capital increase of up to 35% - with subscription rights for all shareholders.
Streamlining structures
In the fight against bureaucracy, Bayer has made significant progress in less than two years, reducing the number of hierarchy levels, positions, and staff. The company aims to grant more decision-making freedom to employees and save €800 million this year, contributing to the goal of saving €2 billion by 2026.
Crop Science to grow stronger than the market
As a fifth strategic priority, Bayer added the profitability of Crop Science. The division aims to grow stronger than the market and generate more than €3.5 billion in additional revenue through innovations by 2029. The EBITDA margin before special effects is targeted to be in the mid-20 percent range.
Business Year 2024
In the business year 2024, Bayer achieved its adjusted goals with revenue of €46.6 billion, a 1% increase currency and portfolio adjusted. The company expects 2025 to be the most challenging year in its turnaround, with revenue approximately at the previous year's level and results and free cash flow below that. A better business development is anticipated from 2026 onwards.
Guru Ramamurthy appointed new CFO of Bayer's Crop Science division
Guru Ramamurthy has been appointed as the new Chief Financial Officer (CFO) of Bayer's Crop Science division. He will succeed Oliver Rittgen on July 1, 2025. Ramamurthy has an impressive track record in transformations and brings a holistic perspective to the business.